[spin-off China business to be listed in Hong Kong? AstraZeneca China President response: rumors] June 19, in response to foreign media reports that AstraZeneca has made plans to spin off its China business and plan to list separately in Hong Kong, Wang Lei, executive vice president of AstraZeneca Global and President of International Business and China, responded on June 19: "rumors!" (first Finance)